STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 72 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,002,000 | -46.3% | 1,962 | -21.9% | 0.00% | – |
| Q2 2021 | $7,458,000 | -58.1% | 2,511 | -61.0% | 0.00% | – |
| Q1 2021 | $17,783,000 | -24.4% | 6,443 | -33.5% | 0.00% | – |
| Q4 2020 | $23,530,000 | +22.4% | 9,683 | +5.8% | 0.00% | – |
| Q3 2020 | $19,219,000 | +179.8% | 9,152 | +403.7% | 0.00% | – |
| Q2 2020 | $6,868,000 | -67.4% | 1,817 | -83.7% | 0.00% | – |
| Q1 2020 | $21,051,000 | +16.6% | 11,138 | +28.9% | 0.00% | – |
| Q4 2019 | $18,053,000 | +355.1% | 8,638 | +420.4% | 0.00% | – |
| Q3 2019 | $3,967,000 | +2476.0% | 1,660 | +5254.8% | 0.00% | – |
| Q1 2019 | $154,000 | +10.8% | 31 | 0.0% | 0.00% | – |
| Q4 2018 | $139,000 | -99.7% | 31 | -99.4% | 0.00% | – |
| Q1 2018 | $48,427,000 | +12.9% | 5,472 | -7.5% | 0.00% | – |
| Q4 2017 | $42,906,000 | +190.7% | 5,918 | +176.7% | 0.00% | – |
| Q3 2017 | $14,759,000 | -10.1% | 2,139 | -6.9% | 0.00% | – |
| Q2 2017 | $16,424,000 | – | 2,297 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 5,376,039 | $47,309,000 | 51.34% |
| Lyon Street Capital, LLC | 3,182,149 | $28,162,000 | 9.07% |
| Opaleye Management Inc. | 1,590,000 | $14,071,000 | 4.02% |
| Broadfin Capital, LLC | 2,793,752 | $24,725,000 | 3.85% |
| Vivo Capital, LLC | 1,918,132 | $16,975,000 | 2.40% |
| ARMISTICE CAPITAL, LLC | 3,372,000 | $29,842,000 | 2.28% |
| PRECEPT MANAGEMENT LLC | 470,000 | $4,160,000 | 1.73% |
| NEA Management Company, LLC | 4,141,308 | $36,651,000 | 1.63% |
| Harvest Capital Strategies LLC | 825,000 | $7,301,000 | 1.14% |
| Granite Point Capital Management, L.P. | 567,895 | $5,026,000 | 0.49% |